Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity-Reference-Cited by-同舟云学术

Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity

Published:2015-09-25 Issue:6 Volume:31 Page:1048-1062
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Chłoń-Rzepa Grażyna¹,Bucki Adam¹,Kołaczkowski Marcin¹,Partyka Anna²,Jastrzębska-Więsek Magdalena²,Satała Grzegorz³,Bojarski Andrzej J.³,Kalinowska-Tłuścik Justyna⁴,Kazek Grzegorz⁵,Mordyl Barbara⁶,Głuch-Lutwin Monika⁶,Wesołowska Anna²

Affiliation:

1. Department of Medicinal Chemistry, Jagiellonian University Medical College, Kraków, Poland,

2. Department of Clinical Pharmacy, Jagiellonian University Medical College, Kraków, Poland,

3. Department of Medicinal Chemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland,

4. Department of Crystal Chemistry and Crystal Physics, Faculty of Chemistry, Jagiellonian University, Kraków, Poland,

5. Department of Pharmacological Screening, Jagiellonian University Medical College, Kraków, Poland, and

6. Department of Pharmacobiology, Jagiellonian University Medical College, Kraków, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/14756366.2015.1088844

Reference66 articles.

1. Atypical antipsychotic drug actions: unitary or multiple mechanisms for ‘atypicality’?

2. Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

3. Discovery of potential antipsychotic agents possessing pro-cognitive properties

4. Aripiprazole, a novel antipsychotic agent: Dopamine D2 receptor partial agonist

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

2. Robust and predictive QSAR models for predicting the D2, 5-HT1A, and 5-HT2A inhibition activities of fused tricyclic heterocycle piperazine (piperidine) derivatives as atypical antipsychotic drugs;Journal of Molecular Structure;2022-07

3. Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease;Bioorganic & Medicinal Chemistry Letters;2021-10

4. Novel medium-sized di(het)areno-fused 1,4,7-(oxa)thiadiazecines as probes for aminergic receptors;Mendeleev Communications;2021-07

5. Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies;Current Medicinal Chemistry;2019-10-16